Hamadneh Sondus A, Nueirat Saja A, Qadoomi' Jamal, Shurrab Mohammed, Qunibi Wajeh Y, Hamdan Zakaria
Department of Internal Medicine and An Najah National University, Nablus, Palestine, USA.
Department of Nursing, An Najah National University, Nablus, Palestine, USA.
Saudi J Kidney Dis Transpl. 2018 Jan-Feb;29(1):120-126. doi: 10.4103/1319-2442.225184.
Vascular access complications are common in patients with end-stage kidney disease who are receiving maintenance hemodialysis (HD) and are responsible for an enormous burden of morbidity and mortality among these patients. Differences in the all-cause mortality rate and hospitalization between dialysis catheter use and arteriovenous (AV) vascular access use have not been documented in our HD population. We performed a 12-month prospective analysis of our HD patients from four dialysis centers. We examined all-cause mortality and hospitalization in patients being dialyzed through HD catheters as compared to patients with AV access. A total of 382 patients were included in the study. Of these, 88 had catheters and 294 had AV accesses. Seventy-eight percent of all catheters were temporary nontunneled dialysis catheters. The overall gross mortality rate for all patients was 14.7%. Gross mortality was significantly lower among AV access group compared to the catheter group (12.2% vs. 22.7%; P = 0.015). Catheter use was associated with a relative hazard ratio (HR) of 1.85 [95% confidence interval (CI), 1.13-3.03] compared with use of an AV access. Hospitalization rate was also significantly lower among patients with AV access versus patients who used catheters (27.6% vs. 46.6%; P = 0.006). The risk of hospitalization was also higher in catheter users with a relative HR of 1.69 (95% CI, 1.26-2.26) compared with use of AV access. In our HD population where the majority of catheters were temporary nontunneled catheters, dialysis catheter use was associated with higher mortality and increased hospitalization rates compared with AV access. These results emphasize the urgent need to minimize the use of dialysis catheters, in order to reduce mortality and hospitalization rates among HD patients.
血管通路并发症在接受维持性血液透析(HD)的终末期肾病患者中很常见,并且是这些患者发病和死亡的巨大负担的原因。在我们的血液透析人群中,尚未记录透析导管使用与动静脉(AV)血管通路使用之间全因死亡率和住院率的差异。我们对来自四个透析中心的血液透析患者进行了为期12个月的前瞻性分析。我们检查了通过HD导管进行透析的患者与AV通路患者的全因死亡率和住院情况。共有382名患者纳入研究。其中,88名使用导管,294名使用AV通路。所有导管中有78%是临时非隧道式透析导管。所有患者的总粗死亡率为14.7%。与导管组相比,AV通路组的粗死亡率显著更低(12.2%对22.7%;P = 0.015)。与使用AV通路相比,使用导管的相对风险比(HR)为1.85 [95%置信区间(CI),1.13 - 3.03]。AV通路患者的住院率也显著低于使用导管的患者(27.6%对46.6%;P = 0.006)。与使用AV通路相比,导管使用者住院风险也更高,相对HR为1.69(95% CI,1.26 - 2.26)。在我们的血液透析人群中,大多数导管是临时非隧道式导管,与AV通路相比,使用透析导管与更高的死亡率和更高的住院率相关。这些结果强调迫切需要尽量减少透析导管的使用,以降低血液透析患者的死亡率和住院率。